Published in Cancer Weekly, May 25th, 1998
P. Schwarzenberger, representing colleagues from Louisiana State University Medical Center, presented results from their clinical trial at the 34th Annual Meeting of the American Society of Clinical Oncology, held May 16-19, 1998, in Los Angeles, California (abstract "Treatment of Three Patients with Malignant Mesothelioma with the Gene Modified Cell Line PA1-STK").
"Our group has developed a clinical phase I study for the treatment of malignant mesothelioma using PA1-STK cells [an ovarian cancer cell line that was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1998-05-25)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.